Sommerauer Laura, Philipp Alois, Lubnow Matthias, Müller Thomas, Lunz Dirk, Hofmann Hans-Stefan, Ried Michael
Abteilung für Thoraxchirurgie, Universitätsklinikum Regensburg, Regensburg.
Fachbereich Kardiotechnik, Universitätsklinikum Regensburg, Regensburg.
Zentralbl Chir. 2019 Feb;144(1):93-99. doi: 10.1055/a-0721-1983. Epub 2018 Oct 15.
Patients with severe respiratory failure and veno-venous extracorporeal membrane oxygenation (vv-ECMO) often require diagnostic or therapeutic thoracic surgery.
Retrospective analysis of prospectively collected data (Regensburg ECMO Registry) on all patients requiring vv-ECMO between December 2010 and December 2016 due to acute lung failure (ALF) with diagnostic or therapeutic thoracic surgery. Endpoints were the indications for thoracic surgery as well as postoperative morbidity and in-hospital mortality.
A total of 418 patients (male n = 285, 68%, mean age 50.0 ± 16.5 years) with severe respiratory insufficiency refractory to conventional therapy required vv-ECMO. Indications for vv-ECMO were ALF due to pneumonia (59.8%), postoperative (18.7%), posttraumatic (9.8%), after chemotherapy (2.8%) and others (8.9%). Overall, in 24.4% (n = 102) of patients with vv-ECMO surgery was performed. Of these, 28.4% (n = 29) of patients required thoracic surgery. Primary indications for thoracic surgery were most frequently therapeutic due to hemothorax (n = 13; 44.8%), followed by carnifying pneumonia/pulmonary abscess (n = 5; 17.2%), pleural empyema (n = 3; 10.3%) and others (n = 3; 10.3%). In patients with interstitial lung disease of unknown origin (n = 5; 17.2%), diagnostic pulmonary biopsy was performed. For initial thoracic intervention thoracotomy was carried out in 93.1% (n = 27) of patients, whereas only two patients (6.9%) received thoracoscopy. At least one repeated thoracotomy was performed in 15 patients (51.7%) and nine patients (31.0%) underwent more than two surgeries. In-hospital mortality of patients with thoracic surgery (44.8%) was higher than in patients without thoracic surgery (35.7%; p = 0.326).
Thoracic surgery in patients with vv-ECMO warrants strict indications, because postoperative complications are common and surgical revision (58,6%) is often required. Therefore, ECMO therapy should only be carried out in specialised centers with thoracic surgery.
患有严重呼吸衰竭且需要静脉-静脉体外膜肺氧合(vv-ECMO)的患者通常需要进行诊断性或治疗性胸外科手术。
对前瞻性收集的数据(雷根斯堡ECMO登记处)进行回顾性分析,这些数据来自2010年12月至2016年12月期间因急性肺衰竭(ALF)而需要vv-ECMO且接受诊断性或治疗性胸外科手术的所有患者。终点指标为胸外科手术的指征以及术后发病率和院内死亡率。
共有418例患者(男性n = 285例,占68%,平均年龄50.0±16.5岁)因常规治疗难以缓解的严重呼吸功能不全而需要vv-ECMO。vv-ECMO的指征包括肺炎所致ALF(59.8%)、术后(18.7%)、创伤后(9.8%)、化疗后(2.8%)以及其他情况(8.9%)。总体而言,24.4%(n = 102)接受vv-ECMO的患者进行了手术。其中,28.4%(n = 29)的患者需要进行胸外科手术。胸外科手术的主要指征最常见的是因血胸进行治疗(n = 13例;44.8%),其次是机化性肺炎/肺脓肿(n = 5例;17.2%)、胸腔积脓(n = 3例;10.3%)以及其他情况(n = 3例;10.3%)。对于病因不明的间质性肺疾病患者(n = 5例;17.2%),进行了诊断性肺活检。对于初次胸外科干预措施而言,93.1%(n = 27)的患者进行了开胸手术,而只有2例患者(6.9%)接受了胸腔镜检查。15例患者(51.7%)至少进行了一次重复开胸手术,9例患者(31.0%)接受了两次以上手术。接受胸外科手术患者的院内死亡率(44.8%)高于未接受胸外科手术的患者(35.7%;p = 0.326)。
接受vv-ECMO的患者进行胸外科手术需要严格掌握指征,因为术后并发症很常见,且经常需要进行再次手术(58.6%)。因此,ECMO治疗应仅在具备胸外科手术条件的专业中心进行。